Financial & Business News

PXF offers diversified exposure to developed-market ex-US stocks with solid fundamentals, but its performance still lags behind US equities over multiple timeframes. Tariff disruptions have a limited impact on PXF due to moderate Asia exposure, but global trade tensions remain a risk to watch. Despite strong inflows into EU and Japanese equities, US markets remain more resilient and continue to outperform international peers.

EPR Properties is a 'buy' again after strong Q1 2025 results, capital recycling progress, and increased guidance. Management's strategic asset sales and reinvestment into experiential assets boost liquidity and support future growth. Q1 2025 beat Wall Street expectations, with AFFO per share up 8% year-over-year and guidance raised for 2025.

Lowe's on Wednesday stood by its full-year forecast, despite reporting quarterly sales that fell just short of Wall Street's expectations.

Shares of Lowe's Cos. (LOW) rose in premarket trading Wednesday after the home-improvement retailer posted first-quarter profit above analysts' estimates and affirmed its full-year outlook.

Apple (AAPL) returned Epic Games' "Fortnite" to its U.S. App Store on Tuesday, five years after it removed the popular video game from iPhones and iPads in the country.

AVVIY and SMGZY made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 21, 2025.

D-Wave Quantum QBTS shares soared over 25% on Tuesday after the company announced its next-generation Advantage quantum computing system. Featuring D-Wave's most advanced quantum processor to date, the Advantage2 system is commercial-grade, and built to address real-world use cases in areas such as optimization, materials simulation and artificial intelligence (AI).

For decades, Universal Orlando Resort was a pit stop on a vacationer's way to the “Most Magical Place on Earth,” Walt Disney World.

Regeneron acquired 23andMe for $256M, gaining 15M DNA profiles to enhance R&D, but the benefits are years away and the risks are immediate. Eylea franchise revenues dropped 26% year-over-year as biosimilars entered the market, stalling overall company growth. Dupixent continues strong growth with new approvals in COPD and CSU, keeping Regeneron profitable despite challenges.

Driving enhanced operational efficiency and observability with Infosys AIOps Insights and LogicMonitor's Edwin AI BENGALURU, India and SANTA BARBARA, Calif. , May 21, 2025 /PRNewswire/ -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next generation digital services and consulting, today announced its strategic collaboration with LogicMonitor, a leading SaaS-based hybrid observability platform powered by artificial intelligence (AI).